GordonLa, SimonE.R., RichardS.V., PerkinsH.A.Studies in regional heparinization. N Engl J Med1956; 255: 1063.
2.
SchwartzR.D., PortF.K.Preventing hemorrhage in high-risk hemodialysis: Regional versus low dose heparin. Kidney Int1979; 16: 513.
3.
PinnickR.V., WiegmannT.B., DiederichD.A.Regional citrate anticoagulation for hemodialysis in patient at high risk for bleeding. N Engl J Med1983; 308: 258.
4.
CrowJ.W., DubrowR., SwartzR., CatoA., FlamenbaumW.Hemorrhage during hemodialysis: Flolan (epoprostenol prostacyclin) versus heparin. (Abst) International Conference on Prostaglandins. Florence, Italy, June 2–6, 1986.
5.
RossiR., FarmaA., MinorettiC.Il Defibrotide: un'alternativa all'eparina in emodialisi. Giorn It Nefrol1988; 5: 125.
6.
BouayedF., RottembourgJ., DurandeJ.P.Successful regular hemodialysis session without any anticoagulant drug in patients with high bleeding risk. Proc Eur Dial Transplant Forum (Abst).1979; 12.
7.
CaruanaR.J., RajaR.M., BushJ.V.Heparin free dialysis: Comparative data and results in high risk patients. Kidney Int1987; 31: 1351.
8.
TarchiniR., BottiP.L., BaroniC.Interazione tra sangue e fibra cava in polisulfone nell'emofiltrazione ad alti flussi: osservazioni in microscopia elettronica a scansione. In: l'emodiafiltrazione e i trattamenti ad alti flussi.Milano: Wichtig Editore1989; 149.